| Page 27 | Cafepharma

You are here

Primary tabs

ITBMed Receives $67 Million to Advance Possible Breakthrough Transplant Drug Siplizumab

Post date: April 4, 2018 - 9:47pm

Roche Acquires MS Remyelination Program from Versant Ventures

Post date: April 4, 2018 - 8:48am

First patient dosed in unique biomarker guided Ph III study of enzastaurin + R-CHOP in high-risk diffuse large B-cell lymphoma (DLBCL)

Post date: April 4, 2018 - 8:26am

Propeller Health uses digital data from inhalers to successfully reduce asthma symptoms in large-scale real world study

Post date: April 3, 2018 - 12:31pm

Results from Third of Three Pivotal Trials of Cariprazine in Bipolar I Depression Mostly Positive

Post date: April 3, 2018 - 9:08am

Citizen Petition Watch - Increased Activity Around Ditropan XL

Post date: April 2, 2018 - 5:25pm

Healthcare on the Hill - Update - H.R.5298 a bill that would classify all opioid mu receptor agonists schedule I

Post date: April 2, 2018 - 2:40pm

Radius Health Initiates Phase III Trial of Osteoporosis Injection Drug for Males

Post date: April 2, 2018 - 9:53am

Why FDA News About Alkermes ALKS 5461 Studies Is Not A Complete Surprise

Post date: April 2, 2018 - 9:33am

FDA Rejects Alkermes NDA for Major Depressive Disorder Drug ALKS 5461

Post date: April 2, 2018 - 8:53am

Pages